The goal of this clinical trial is to investigate the safety, the activity of VERT-002(PFL-002), and the optimal safe dose to be used, in participants with solid tumorsincluding non-small cell lung cancer.
The goal of this clinical trial is to investigate the safety, the activity of VERT-002 (PFL-002), and the optimal safe dose to be used, in participants with solid tumors including non-small cell lung cancer.
